Task: Answer Verification
Input (English): Question: Does recombinant human thyroid stimulating hormone acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma?
Answer: In a small group of subjects with a history of DTC on L-T4 regimen, our study did not support an acute direct effect of TSH on OPG and RANK-L.
Output (English): no